{
    "clinical_study": {
        "@rank": "63997", 
        "brief_summary": {
            "textblock": "OBJECTIVE:\n\n      I.  Evaluate the efficacy of fluconazole in patients with lymphocutaneous or visceral\n      sporotrichosis."
        }, 
        "brief_title": "Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis", 
        "completion_date": "August 1996", 
        "condition": "Sporotrichosis", 
        "condition_browse": {
            "mesh_term": "Sporotrichosis"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Patients are treated with daily oral fluconazole for up to 24 months. Follow-up continues\n      for at least 1 year."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics-- Presumptive evidence of sporotrichosis Culture-proven\n        sporotrichosis determined on study Relapsing disease following antifungal therapy eligible\n        if culture positive for Sporothrix schenckii prior to entry No life-threatening disease No\n        central nervous system sporotrichosis --Prior/Concurrent Therapy-- No concurrent drugs\n        known to react with fluconazole No more than 3 days of systemic antifungals for current\n        sporotrichosis episode --Patient Characteristics-- Hepatic: Liver function tests no\n        greater than 5 times normal Other: No HIV infection No pregnant or nursing women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": "30", 
        "firstreceived_date": "February 24, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004938", 
            "org_study_id": "199/11815", 
            "secondary_id": "NIAID-MSG-11815"
        }, 
        "intervention": {
            "intervention_name": "fluconazole", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Fluconazole"
        }, 
        "keyword": [
            "fungal infection", 
            "rare disease", 
            "sporotrichosis"
        ], 
        "lastchanged_date": "June 8, 2006", 
        "overall_official": {
            "affiliation": "University of Alabama at Birmingham", 
            "last_name": "William Dismukes", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "reference": {
            "PMID": "8824965", 
            "citation": "Kauffman CA, Pappas PG, McKinsey DS, Greenfield RA, Perfect JR, Cloud GA, Thomas CJ, Dismukes WE. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis. 1996 Jan;22(1):46-50."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004938"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Alabama at Birmingham", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "August 1996", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2000"
    }, 
    "geocoordinates": {}
}